Steve Jobs’ son watched him battle cancer; now he’s fighting the disease with $1bn
Reed Jobs, son of Apple co-founder Steve Jobs, has launched an oncology-focused investment firm called Yosemite to support early-stage cancer research. The firm manages over $1 billion in assets, combining venture capital with philanthropy to accelerate the development of new treatments.
Why it matters
It highlights a significant shift in how private capital and philanthropy are being combined to address complex medical challenges like cancer.
Reed Jobs was 12 when his father, Apple co-founder Steve Jobs, was diagnosed with a rare form of pancreatic cancer. Eight years later, Steve died at 56, while Reed was an undergraduate at Stanford. The experience shaped Reed’s interest in cancer research, leading him to spend summers working in oncology laboratories as a teenager before eventually moving into healthcare investing. In 2023, he launched Yosemite, an oncology-focused investment firm that combines venture capital with philanthropic funding. Yosemite initially launched with more than $200 million. By early 2026, the firm had raised another $200 million-plus for its second fund and said it was managing more than $1 billion in assets.Reed Jobs’ childhood changed after Steve Jobs’ diagnosisReed became interested in cancer after seeing his father diagnosed when he was 12. Steve Jobs had been diagnosed with a pancreatic neuroendocrine tumour, a rare form of pancreatic cancer.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in